Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer.

doi:10.1016/j.cyto.2018.07.006

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer.

Cytokine - 1 Jan 2019

Chatrabnous Nazanin, Ghaderi Abass, Ariafar Ali, Razeghinia Mohammad Sadegh, Nemati Maryam, Jafarzadeh Abdollah

Abstract excerpt

IL-35 is an immunosuppressive cytokine that is largely synthesized by regulatory T (Treg) cells and may inhibit antitumor immune responses. This investigation aimed to determine the serum IL-35 concentrations and a single nucleotide polymorphism (SNP) in position of rs3761548, within the promoter region of FOXP3 gene, in patients with prostate cancer (PC). The blood specimens were obtained from 150 PC patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Alleles

Share to Forkhead Transcription Factors

Share to Interleukins

Share to Neoplasm Proteins

Share to Neoplasm Staging

Share to Polymorphism, Restriction Fragment Length

Share to Prostatic Neoplasms

Source

Open in PubMed

Identifiers

PMID: 30057362
DOI: 10.1016/j.cyto.2018.07.006

Genes

FOXP3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer.PMID 30057362Read ↗

Association of Foxp3 rs3761548 polymorphism with cytokines concentration in gastric adenocarcinoma patients.Semantic proximity Read ↗

Association of elevated interleukin-33 serum levels with tumorstages in patients with prostate cancer.Semantic proximity Read ↗

Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.Semantic proximity Read ↗

Association of interleukine-18 polymorphisms with susceptibility to prostate cancer in Iranian population.Semantic proximity Read ↗

Interleukins-6 -174G/C (rs1800795) and -572C/G (rs1800796) polymorphisms and prostate cancer risk.Semantic proximity Read ↗

4-bp insertion/deletion (rs3783553) polymorphism within the 3'UTR of IL1A contributes to the risk of prostate cancer in a sample of Iranian population.Semantic proximity Read ↗

Circulating levels of interleukin-35 in patients with multiple sclerosis: evaluation of the influences of FOXP3 gene polymorphism and treatment program.Semantic proximity Read ↗

Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk.Semantic proximity Read ↗

FOXP3rs3761548 gene variant and interleukin-35 serum levels as biomarkers in patients with multiple sclerosis.Semantic proximity Read ↗

The Relationship Between Serum Concentration of Interleukin-35 and FoxP3 Polymorphism in Patients Undergoing Coronary Artery Bypass Graft Surgery.Semantic proximity Read ↗

[Insertion/deletion polymorphism of IL1A 3'-UTR associated with the susceptibility of prostate cancer ].Semantic proximity Read ↗

Role of interleukin-6 gene polymorphisms in the development of prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.